GSK963 (Racemate)

CAS No. 2049868-46-2

GSK963 (Racemate)( —— )

Catalog No. M20223 CAS No. 2049868-46-2

GSK963 (Racemate) a structurally distinct potent and selective inhibitor of RIP1 kinase(IC50=29 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 39 Get Quote
5MG 65 Get Quote
10MG 110 Get Quote
25MG 222 Get Quote
50MG 357 Get Quote
100MG 524 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GSK963 (Racemate)
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK963 (Racemate) a structurally distinct potent and selective inhibitor of RIP1 kinase(IC50=29 nM).
  • Description
    GSK963 (Racemate) a structurally distinct potent and selective inhibitor of RIP1 kinase(IC50=29 nM).
  • In Vitro
    ——
  • In Vivo
    Animal Model:C57BL/6 mice.Dosage:0.2 mg/kg, 2 mg/kg, 10?mg/kg.Administration:IP once.Result:Protected mice from TNF+zVAD-induced hypothermia.
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    TNF
  • Recptor
    RIP1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2049868-46-2
  • Formula Weight
    230.31
  • Molecular Formula
    C14H18N2O?
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:40 mg/mL (173.67 mM)
  • SMILES
    CC(C)(C)C(=O)N1N=CCC1c1ccccc1
  • Chemical Name
    22-Dimethyl-1-(5(S)-phenyl-45-dihydro-pyrazol-1-yl)-propan-1-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Berger SB et al. Characterization of GSK'963: a structurally distinct potent and selective inhibitor of RIP1 kinase. Cell Death Discov. 2015 Jul 27;1:15009.
molnova catalog
related products
  • INH1

    INH1 is a cell-permeable Hec1 inhibitor that specifically disrupts the Hec1/Nek2 interaction.

  • Varlilumab

    Varlilumab (CDX-1127) is a novel human IgG1 anti-CD27 monoclonal antibody with antitumor activity, useful for studying advanced solid tumors.

  • (Rac)-Benpyrine

    (Rac)-Benpyrine is a potent and orally active inhibitor of TNF-α.